Therapeutic Approach to Calcified Coronary Lesions: Disruptive Technologies

Keyvan Karimi Galougahi1,2,3, Evan Shlofmitz4, Allen Jeremias4,5

  • 1Royal Prince Alfred Hospital, Sydney, Australia.

Insights

Treating calcified coronary lesions is crucial for better outcomes. Advanced intravascular imaging and new atherectomy devices improve lesion modification and stent expansion in patients with coronary artery disease.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Devices

Background:

  • Moderate to severe calcification affects about one-third of coronary lesions in patients with ischemic heart disease and acute coronary syndromes.
  • Calcified lesions are associated with poorer procedural results and long-term outcomes.

Purpose of the Study:

  • To review the current state-of-the-art in evaluating and treating calcified coronary lesions.

Main Methods:

  • Review of current literature and technologies for the assessment and treatment of calcified coronary lesions.
  • Discussion of intravascular imaging modalities (intravascular ultrasound, optical coherence tomography) for lesion assessment.
  • Overview of established and novel technologies for coronary calcium modification (rotational atherectomy, excimer laser, orbital atherectomy, intravascular lithotripsy).

Main Results:

  • Intravascular imaging is essential for guiding percutaneous coronary intervention in severely calcified lesions.
  • New technologies like orbital atherectomy and intravascular lithotripsy enhance coronary calcium modification and facilitate stent expansion.
  • Achieving calcium fracture improves lesion compliance and is critical for optimal stent implantation.

Conclusions:

  • An algorithmic approach integrating intravascular imaging with various atherectomy technologies enables safe and effective treatment of heavily calcified coronary lesions.
  • Intravascular imaging-guided strategies are key to optimizing stent expansion and patient outcomes.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
121
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
110
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
966
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
111
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
181
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
94